DK248484A - Isoquinolinderivater - Google Patents

Isoquinolinderivater Download PDF

Info

Publication number
DK248484A
DK248484A DK248484A DK248484A DK248484A DK 248484 A DK248484 A DK 248484A DK 248484 A DK248484 A DK 248484A DK 248484 A DK248484 A DK 248484A DK 248484 A DK248484 A DK 248484A
Authority
DK
Denmark
Prior art keywords
image
formula
isoquinoline
alkoxyphenyl
halophenyl
Prior art date
Application number
DK248484A
Other languages
Danish (da)
English (en)
Other versions
DK248484D0 (da
Inventor
Hans Bruderer
Richard Wightman Kierstead
Jr John G Mullin
Keiji Nakamura
Jay Philip O'brien
Mitsuru Tateishi
Sidney Teitel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK248484D0 publication Critical patent/DK248484D0/da
Publication of DK248484A publication Critical patent/DK248484A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)
DK248484A 1983-05-19 1984-05-17 Isoquinolinderivater DK248484A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/496,327 US4544657A (en) 1983-05-19 1983-05-19 Substituted isoquinolines

Publications (2)

Publication Number Publication Date
DK248484D0 DK248484D0 (da) 1984-05-17
DK248484A true DK248484A (da) 1984-11-20

Family

ID=23972146

Family Applications (1)

Application Number Title Priority Date Filing Date
DK248484A DK248484A (da) 1983-05-19 1984-05-17 Isoquinolinderivater

Country Status (20)

Country Link
US (1) US4544657A (en:Method)
EP (1) EP0126480B1 (en:Method)
JP (1) JPS59222478A (en:Method)
KR (1) KR840009102A (en:Method)
AT (1) ATE32072T1 (en:Method)
AU (1) AU570044B2 (en:Method)
CA (1) CA1243028A (en:Method)
DE (1) DE3468875D1 (en:Method)
DK (1) DK248484A (en:Method)
ES (1) ES8601141A1 (en:Method)
FI (1) FI81795C (en:Method)
GR (1) GR82015B (en:Method)
HU (1) HU192555B (en:Method)
IL (1) IL71860A (en:Method)
MC (1) MC1597A1 (en:Method)
NO (1) NO159271C (en:Method)
NZ (1) NZ208186A (en:Method)
PH (1) PH19670A (en:Method)
PT (1) PT78618A (en:Method)
ZA (1) ZA843748B (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681954A (en) * 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
RU2124511C1 (ru) * 1993-05-14 1999-01-10 Фармасьютикал Ко., Лтд Производные пиперазина
NZ295546A (en) * 1994-10-05 1999-01-28 Glaxo Wellcome Inc Parenteral medicament containing n-{4-[2-1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)-ethyl]-phenyl}- 9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide, surfactant, and buffer
FR2840896B1 (fr) * 2002-06-18 2005-04-08 Sanofi Synthelabo Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
MX2008001292A (es) 2005-07-29 2008-03-25 Hoffmann La Roche Nuevos derivados de indol-3-il-carbonil-piperidina y piperazina.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759443A (fr) * 1970-09-15 1971-04-30 I F L O Istituto Farmacologico Nouveau derive papaverolinique et procede de preparation relatif
DE2818423A1 (de) * 1978-04-27 1979-11-08 Hoechst Ag Neue isochinolinderivate und verfahren zu ihrer herstellung
IN154317B (en:Method) * 1979-07-19 1984-10-13 Andre Buzas
DE3034001A1 (de) * 1980-09-10 1982-04-22 Hoechst Ag, 6000 Frankfurt Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung

Also Published As

Publication number Publication date
FI841992A7 (fi) 1984-11-20
ES532603A0 (es) 1985-11-01
ATE32072T1 (de) 1988-02-15
PT78618A (en) 1984-06-01
NO159271C (no) 1988-12-14
FI81795B (fi) 1990-08-31
HU192555B (en) 1987-06-29
ES8601141A1 (es) 1985-11-01
NO842003L (no) 1984-11-20
HUT34185A (en) 1985-02-28
FI81795C (fi) 1990-12-10
FI841992A0 (fi) 1984-05-17
ZA843748B (en) 1985-01-30
MC1597A1 (fr) 1985-05-09
CA1243028A (en) 1988-10-11
AU570044B2 (en) 1988-03-03
US4544657A (en) 1985-10-01
IL71860A (en) 1987-10-30
KR840009102A (ko) 1984-12-24
AU2835684A (en) 1984-11-22
EP0126480B1 (de) 1988-01-20
JPS59222478A (ja) 1984-12-14
IL71860A0 (en) 1984-09-30
NZ208186A (en) 1987-06-30
EP0126480A1 (de) 1984-11-28
DK248484D0 (da) 1984-05-17
DE3468875D1 (en) 1988-02-25
GR82015B (en:Method) 1984-12-12
NO159271B (no) 1988-09-05
PH19670A (en) 1986-06-09

Similar Documents

Publication Publication Date Title
PT88060A (pt) Processo para a preparacao de polietilenoglicol-carbaminatos
FI873809A0 (fi) Piperidinfoereningar och deras framstaellning och anvaendning.
DK10086A (da) Guanidinderivater
MY102277A (en) Quinoline compounds
DK163287D0 (da) 1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser
NO170330C (no) Fremgangsmaate for fremstilling av vesentlig optisk rent monohydrat av s-(-)-propyl-2',6'-pipekoloksylididhydroklorid
ES8601201A1 (es) Procedimiento para preparar derivados de imidazolina
DK248484D0 (da) Isoquinolinderivater
OA07768A (fr) Dérivés d'anillines fongicides.
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
ATE17352T1 (de) Cephalosporinverbindungen, ihre herstellung und sie enthaltende medikamente.
ATE36325T1 (de) Derivate von 5-halovinyl-2'-deoxyuridin.
SE8601963L (sv) O-sulfaterade beta-laktamhydroxamsyror
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
ES464483A1 (es) Procedimiento para la obtencion de ortoaminoacetofenonas.
SE8400629L (sv) Basiska oximetrar
IT8025595A0 (it) Procedimento per misurare l'aumento di batteri.
ATE15201T1 (de) Organophosphat-derivate.
SE8600960D0 (sv) Skrivplatta for hemiplegiker "barbro-plattan"
GB2021587A (en) Benzoquinolizines
RO89246A2 (ro) Solutie pentru retusul placilor presensibilizate pentru tiparul plan
IT8304228V0 (it) L'arte delle trattative commerciali
IT8619891A0 (it) Procedimento per la monosolfonazione di composti finilindanici e composizioni cosi'ottenute.
NO172492C (no) Fremgangsmaate for fremstilling av alkalimetall- eller jordalkalimetallsalter av n5-formyl-5,6,7,8-tetrahydrofolsyre
RO88108A2 (ro) Medicament de uz veterinar

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment